34 results on '"Leong, Rupert W."'
Search Results
2. Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD
3. Ten missteps in the management of inflammatory bowel disease in Asia: An expert report by the Asian Pacific Association of Gastroenterology Working Group on Inflammatory Bowel Disease
4. Meta‐analysis: Persistence of advanced therapies in the treatment of inflammatory bowel disease
5. Faecal microbiota transplantation for recurrent C. difficile infections: challenges and improvement opportunities for clinical practice and healthcare systems
6. An update on fecal microbiota transplantation for the treatment of gastrointestinal diseases
7. Superior treatment persistence with ustekinumab in Crohn’s disease and vedolizumab in ulcerative colitis compared with anti‐TNF biological agents: real‐world registry data from the Persistence Australian National IBD Cohort (PANIC) study
8. Risk mitigation in Crohn's disease and ulcerative colitis: Session four summary
9. Tioguanine as an alternative immunomodulator in inflammatory bowel diseases
10. Ustekinumab is effective and safe for ulcerative colitis through 2 years of maintenance therapy
11. The timed barium swallow and its relationship to symptoms in achalasia: Analysis of surface area and emptying rate
12. Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID‐19 pandemic
13. The significance of granulomas in Crohn's disease and inflammatory bowel disease epidemiology in Asia
14. Achalasia diagnosed despite normal integrated relaxation pressure responds favorably to therapy
15. Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission-confounded by the gut microbiome?
16. Validation of the inflammatory bowel disease disability index for self-report and development of an item-reduced version
17. Positioning biologics-A case-based discussion: Anti-tumor necrosis factor biological agents/biosimilars
18. Positioning biological agents: Session two summary
19. Role of hemostatic powders in the management of lower gastrointestinal bleeding: A review
20. Oral and upper gastrointestinal Crohn's disease
21. Serologic antibodies in relation to outcome in postoperative Crohn's disease
22. In the endoscopy unit: Summary
23. Improving the utility of colonoscopy: Recent advances in practice
24. Inflammatory bowel disease‐specific pregnancy knowledge of gastroenterologists against general practitioners and obstetricians
25. Outcomes of single‐dose peri‐procedural antibiotic prophylaxis for endoscopic ultrasound‐guided fine‐needle aspiration of pancreatic cystic lesions
26. Proteomics and metabolomics in inflammatory bowel disease
27. Inflammatory bowel disease in Asia: The start of the epidemic?
28. When to use biological agents in inflammatory bowel disease
29. Comparison of clinical characteristics and management of inflammatory bowel disease in Hong Kong versus Melbourne
30. Colorectal cancer screening practise is influenced by ethnicity of medical practitioner and patient
31. Inflammatory bowel disease in Asia
32. Environmental risk factors in inflammatory bowel disease
33. Resumption of oral intake following percutaneous endoscopic gastrostomy
34. Colorectal cancer in inflammatory bowel disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.